4.5 Article

Microporous polycaprolactone matrices for drug delivery and tissue engineering: the release behaviour of bioactives having extremes of aqueous solubility

Journal

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
Volume 20, Issue 3, Pages 207-212

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/S1773-2247(10)50031-5

Keywords

Polycaprolactone; Microporous; Matrix device; Steroids; Pilocarpine; Ocular delivery; Tissue engineering

Ask authors/readers for more resources

Microporons polycaprolactone (PCL) matrices loaded with hydrophobic steroidal drags or a hydrophilic drug pilocarpine hydrochloride were produced by precipitation casting using solutions of PCL in acetone. The efficiency of steroid incorporation in the final matrix (progesterone (56 %) testosterone (46 %)dexamethasone (80 %)) depended on the nature of the drug initially co-dissolved in the PCL solution. Approximately 90 % w/w of the initial load of progesterone, 85 % testosterone and 50 % dexamethasone was released from the matrices in PBS at 37 degrees C over 8 days. Pilocarpine hydrochloride (PH)-loaded PCL matrices, prepared by dispersion of powder in PCL solution, released 70-90 % of the PH content over 12 days in PBS. Application of the Higuchi model revealed that the kinetics of steroid and PH release were consistent with a Fickian diffusion mechanism with corresponding coefficients of 5.8 x 10(-9) (progesterone), 3.9 x 10(-9) (testosterone), 7.1 x 10(-10) (dexamethasone) and 2.2 x 10(-8) (pilocarpine hydrochloride). The formulation techniques described are expected to be useful for production of implantable, insertable and topical devices for sustained delivery of a range of bioactive molecules of interest in drug delivery and tissue engineering.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available